- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type1 Diabetes Mellitus in South Africa
Total 4170 results
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Mexico, Japan, India, Puerto Rico, China
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Taiwan, China, Mexico, Germany, Poland
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, Italy, United States, Germany, United Kingdom, Russian Federation, Canada, Poland, Puerto Rico, Macedonia, The Former Yugoslav Republic of
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Russian Federation, Slovakia, Spain, Canada, Taiwan, Finland, Hungary, Malaysia, South Africa, United Kingdom, Germany, Australia, Thailand, Ireland, Puerto Rico, Singapore
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery SystemsUnited States
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Mylan Inc.Mylan GmbHCompletedType 1 DiabetesUnited States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
-
Rafic Hariri University HospitalAmerican University of Beirut Medical CenterUnknownUveitis | Diabetic Retinopathy | Choroidal NeovascularizationLebanon
-
PfizerTerminatedDiabetic NeuropathiesNetherlands, United States, Spain, Finland, South Africa, Czechia
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
University of JohannesburgCompletedChronic Tension-type HeadachesSouth Africa
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyFrance, Poland, United States, Belgium, Germany, Spain, India, Romania, South Africa, Canada, Australia, Korea, Republic of, New Zealand, Russian Federation, Brazil, Malaysia, Latvia, Mexico
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, United Kingdom, Germany, Mexico, Romania, Argentina, Canada, Puerto Rico, Israel, Italy, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Japan, Russian Federation, United Kingdom, France, Mexico, South Africa, Turkey, Argentina, Germany, Romania, Brazil, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Finland, Taiwan, United States, Korea, Republic of, China, Australia, Portugal, Japan, India, Russian Federation, Norway, Italy, Mexico, Turkey, Poland, Belgium, Bulgaria, Croatia, Puerto Rico, Romania, Serbia, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Slovakia, United Kingdom, France, Argentina, South Africa, Germany, Slovenia, Netherlands, Romania, North Macedonia, Mexico, Puerto Rico
-
Solvay PharmaceuticalsCompletedType 2 Diabetes | HypogonadismUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico, Russian Federation, United Kingdom, Denmark, France, Israel, Australia, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
Bristol-Myers SquibbCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Israel, Italy, Mexico, Puerto Rico, Russian Federation, Spain, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Taiwan, Finland, Norway, Serbia, South Africa, Turkey, Canada, France, Germany, Korea, Republic of and more
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, United Kingdom, Denmark, France, Austria, Czech Republic, Australia
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
AstraZenecaBristol-Myers SquibbCompletedCardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Bulgaria, Poland, Hungary, Argentina, Australia, Austria, Canada, Germany, Chile
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Germany, Puerto Rico, United Kingdom, Spain, Canada, Brazil, Korea, Republic of, India, Israel, Russian Federation, South Africa
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Germany, Argentina, Brazil, Turkey, Hungary, Italy, Russian Federation, Slovakia, Belgium, Czechia, Greece, Mexico, Romania
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Nova Laboratories LimitedCompletedAcute Lymphoblastic LeukemiaSouth Africa
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany, Lithuania
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
University of SydneyNational Health and Medical Research Council, AustraliaCompletedDiabetic Retinopathy | Macular EdemaAustralia